Avi Ben-Abraham

From Wikipedia, the free encyclopedia

Dr Avi Ben-Abraham is an American scientist. Dr. Ben-Abraham was involved in research work in the fields of low temperature medicine, cryogenics, and human and stem cell cloning. Dr. Ben-Abraham is the founder and former chairman and chief executive officer of Biosante Pharmaceuticals Inc., (formerly Ben-Abraham Technologies inc.) -a publicly traded American biotechnology company, developing its proprietary calcium phosphate nanotechnology (CaP) for vaccine adjuvants and delivery technology for biodefense vaccines. The company signed a CRADA with the U.S. Army for the development of non-injected biodefense vaccines against anthrax, ricin and staph. The company which makes a component of the 'Merrill Lynch Nanotech Index'-NNZ, was also awarded a subcontract for the development of a non-injected anthrax vaccine for the U.S. Department of Defense. In 1999, endorsed by Israel's Prime Minister Benjamin Netanyahu, Dr. Ben-Abraham won the primaries for a top seat on the governing Likud party list of candidates for the Knesset, but was not elected as Likud and Netanyahu were defeated by Labor party leader, former Israeli Defense Forces chief of staff Lt. General Ehud Barak.